Peng Hou

18PUBLICATIONS
11CO-AUTHORS
Molecular targetsHaematological tumoursAutoimmunityBiomolecular modelling and designPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 20, 2026
Disrupting KRAS-AGO2 interaction: a dual-pronged strategy to sensitize chemo-immunotherapy in KRAS-mutated colorectal cancer.

|Apr 20, 2026
TRMT6-Mediated m1A Modification of CDK9 mRNA is a Dual-Pronged Pathogenic Driver for HBV-Related Hepatocellular Carcinoma.

|Dec 18, 2025
Targeting DDOST improves the efficacy of lenvatinib and immunotherapy in hepatocellular carcinoma.

Jun Pu, Jingjing Ma, Yan Liu

|Oct 29, 2025
TET1 loss propels the development of hyperthyroidism by remodeling histone modifications of PAX8 promoter.

Hui Dang, Yan Liu, Ye Zhou

|Jun 16, 2025
Thyrotropin exacerbates insulin resistance by triggering macrophage inflammation in subclinical hypothyroidism.

Haihong Zhang, Zekun Zeng, Yan Liu

|Oct 18, 2024
Advancing Cancer Immunotherapy through Engineering New PD-L1 Degraders: A Comprehensive Study from Small Molecules to PD-L1-Specific Peptide-Drug Conjugates.

Zekun Zeng, Zhiwei Yang, Chenghao Li

Pageof 3

Frequent Collaborators

4 joint publications

Yubo Wang

3 joint publications

Wuyuan Lu

2 joint publications

Peter X Ma

2 joint publications

Wangxiao He